Compare CODI & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODI | RXST |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.2M | 513.1M |
| IPO Year | 2006 | 2021 |
| Metric | CODI | RXST |
|---|---|---|
| Price | $4.96 | $12.56 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 11 |
| Target Price | ★ $18.00 | $11.30 |
| AVG Volume (30 Days) | ★ 1.7M | 850.9K |
| Earning Date | 02-25-2026 | 11-05-2025 |
| Dividend Yield | ★ 19.45% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,788,013,000.00 | $142,085,000.00 |
| Revenue This Year | $41.50 | N/A |
| Revenue Next Year | $8.26 | $4.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.80 | ★ 10.75 |
| 52 Week Low | $5.11 | $6.32 |
| 52 Week High | $24.32 | $39.37 |
| Indicator | CODI | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 35.18 | 67.06 |
| Support Level | $5.18 | $11.84 |
| Resistance Level | $7.72 | $13.22 |
| Average True Range (ATR) | 0.50 | 0.65 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 5.39 | 77.33 |
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.